TGFBR3 and cancer: Dysregulated angiogenesis is considered to be one of the fundamental mechanisms regulating initiation and development of many diseases, such as cancer,20, 32, 33 heart disease34, 35 and inflammation.36, 37 In this study we found that TGFBR3 is a novel target of let‐7a.